Study of Ultrasound To Increase Parental Bonding in Women With Substance Use Disorders

Status unconfirmed · Not applicable

Conditions studied: Substance Use Disorders, Pregnancy

In brief

1. A randomized trial of 3-dimensional vs. 2-dimensional ultrasound, comparing scores on the Maternal Antenatal Attachment Scale (MAAS), a validated instrument measuring maternal attachment as a marker of maternal bonding. The hypothesis is that 3-dimensional ultrasound is better at eliciting maternal attachment than 2-D 2. To assess changes in maternal confidence to stop using drugs and quit/reduce smoking with 3-D vs. 2-D ultrasound. Again, the hypothesis is that 3-D ultrasound will improve the woman's confidence to stop using substances. 3. To evaluate if 3-D ultrasound improves paternal attachment as measured by pre- and post- scores on the Paternal Antenatal Attachment Scale (PAAS). The hypothesis is that 3-D ultrasound will have a greater effect on PAAS scores than 2-D.

Key facts

Study ID

NCT02158429

Run by

University of Hawaii

People needed

120

Starts

2011-04-01

Expected to finish

2016-09-01

Last updated by the study team

2015-06-10

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant women with a history of substance use during pregnancy obtaining prenatal care between 24-32 weeks of pregnancy

You may not qualify if…

• Women less than 18, incarcerated women, women with fetal anomalies previously diagnosed.

Where it is running

• Path Clinic — Honolulu, Hawaii, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.